TR201911149T4 - Dermal enjekte edilebilir steril bileşim. - Google Patents

Dermal enjekte edilebilir steril bileşim. Download PDF

Info

Publication number
TR201911149T4
TR201911149T4 TR2019/11149T TR201911149T TR201911149T4 TR 201911149 T4 TR201911149 T4 TR 201911149T4 TR 2019/11149 T TR2019/11149 T TR 2019/11149T TR 201911149 T TR201911149 T TR 201911149T TR 201911149 T4 TR201911149 T4 TR 201911149T4
Authority
TR
Turkey
Prior art keywords
injectable sterile
sterile composition
hyaluronic acid
crosslinking
dermal
Prior art date
Application number
TR2019/11149T
Other languages
English (en)
Inventor
Bourdon Francois
Meunier Stéphane
Original Assignee
Teoxane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47754646&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201911149(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teoxane filed Critical Teoxane
Publication of TR201911149T4 publication Critical patent/TR201911149T4/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91Injection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Mevcut buluş, çapraz bağlama maddesi olarak en az bir etkili miktarda en az bir endojen poliamin varlığında hiyalüronik asit veya tuzlarından birinin çapraz bağlanmasından elde edilen bir çapraz bağlanmış hiyalüronik asit jel ile ilgilidir, söz konusu çapraz bağlanma, söz konusu hiyalüronik asit ve söz konusu endojen poliaminin birleştirilmesine yardımcı olan koşullar altında gerçekleştirilir.
TR2019/11149T 2012-10-24 2013-10-24 Dermal enjekte edilebilir steril bileşim. TR201911149T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1260146A FR2997014B1 (fr) 2012-10-24 2012-10-24 Composition sterile dermo-injectable

Publications (1)

Publication Number Publication Date
TR201911149T4 true TR201911149T4 (tr) 2019-08-21

Family

ID=47754646

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/11149T TR201911149T4 (tr) 2012-10-24 2013-10-24 Dermal enjekte edilebilir steril bileşim.

Country Status (19)

Country Link
US (2) US9907739B2 (tr)
EP (1) EP2912074B2 (tr)
JP (1) JP6521862B2 (tr)
KR (1) KR102178252B1 (tr)
AU (1) AU2013336274B2 (tr)
BR (1) BR112015009162B1 (tr)
CA (1) CA2888616C (tr)
DK (1) DK2912074T4 (tr)
ES (1) ES2735017T5 (tr)
FR (1) FR2997014B1 (tr)
HR (1) HRP20191196T1 (tr)
HU (1) HUE044362T2 (tr)
PL (1) PL2912074T5 (tr)
PT (1) PT2912074T (tr)
RS (1) RS59079B1 (tr)
RU (1) RU2653729C2 (tr)
SI (1) SI2912074T1 (tr)
TR (1) TR201911149T4 (tr)
WO (1) WO2014064632A1 (tr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6906885B2 (ja) 2014-11-14 2021-07-21 ロレアル しわを減少させるためのマイクロニードルシート
FR3034195B1 (fr) * 2015-03-24 2017-04-21 Teoxane Procede d'evaluation des performances mecaniques d'un gel de comblement
ES2883839T3 (es) * 2016-10-13 2021-12-09 Allergan Inc Hidrogeles de hialuronano coacervados para aplicaciones de relleno dérmico
EP3562468A1 (en) * 2016-12-29 2019-11-06 Nestlé Skin Health SA Micro- or nanoparticular multilamellar vesicles, compositions comprising the same and method for their use in skin care
WO2018122343A1 (en) 2016-12-29 2018-07-05 Nestlé Skin Health Sa Micro- or nanoparticular vesicles comprising crosslinked hyaluronic acid, compositions comprising the same and method for their use in skin care
WO2018122344A1 (en) 2016-12-29 2018-07-05 Nestlé Skin Health Sa Composition comprising a crosslinked hyaluronic acid (ha) in combination with a low-molecular ha and/or an agent stimulating endogenous ha synthesis
CN111727033A (zh) * 2018-02-16 2020-09-29 东洋纺株式会社 防污染剂及皮肤外用组合物
CA3101412A1 (en) 2018-06-15 2019-12-19 Croma-Pharma Gmbh Hydrogel composition comprising a crosslinked polymer
JP7208267B2 (ja) 2018-06-29 2023-01-18 ザ プロクター アンド ギャンブル カンパニー 二相製品
CN112334119A (zh) 2018-06-29 2021-02-05 宝洁公司 双相产品
EP3814021A2 (en) 2018-06-29 2021-05-05 The Procter & Gamble Company Dual phase products dispenser
CA3105709C (en) * 2018-07-06 2024-03-12 Lg Chem, Ltd. Hyaluronic acid filler having high viscoelasticity and high cohesiveness
CN112399862B (zh) * 2018-07-10 2022-07-26 株式会社Lg化学 具有高提拉能力和低注射力的透明质酸填充剂
WO2020111888A1 (ko) * 2018-11-30 2020-06-04 주식회사 엘지화학 히알루론산을 포함하는 활액보충재용 조성물
BR112021012042A2 (pt) * 2018-12-20 2021-09-21 Lg Chem, Ltd. Preenchedor com excelentes propriedades de preenchedor compreendendo hidrogel de ácido hialurônico
JP1665824S (tr) 2019-08-21 2020-08-11
US11497703B2 (en) * 2019-08-30 2022-11-15 The Procter & Gamble Company Packaged hair care composition
US11752074B2 (en) 2020-10-27 2023-09-12 The Procter & Gamble Company Warming conditioner
USD1006632S1 (en) 2020-12-11 2023-12-05 The Procter & Gamble Company Container for hair care products
USD1012718S1 (en) 2020-12-21 2024-01-30 The Procter & Gamble Company Container for hair care product
US20220332902A1 (en) * 2021-04-09 2022-10-20 Colorado School Of Mines Radical crosslinked zwitterionic gels and uses thereof
EP4431551A1 (en) 2021-11-10 2024-09-18 Imeik Technology Development Co., Ltd. Gel material, preparation method therefor, and use thereof
CN113896915B (zh) * 2021-11-10 2024-02-13 爱美客技术发展股份有限公司 一种凝胶材料及其制备方法与应用
WO2023093532A1 (zh) 2021-11-29 2023-06-01 爱美客技术发展股份有限公司 一种复合凝胶、制备方法及应用
IL314231A (en) 2022-01-11 2024-09-01 Wiqo S P A New histories of hyaluronic acid as innovative fillers
WO2023221082A1 (zh) * 2022-05-20 2023-11-23 爱美客技术发展股份有限公司 一种接枝聚合物材料及其制备方法与应用
WO2024040480A1 (zh) * 2022-08-24 2024-02-29 爱美客技术发展股份有限公司 一种凝胶材料及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752843B1 (fr) 1996-08-30 1998-10-16 Sod Conseils Rech Applic Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique
IT1303735B1 (it) 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S Acidi ialuronici reticolati e loro usi medici.
KR100375299B1 (ko) 2000-10-10 2003-03-10 주식회사 엘지생명과학 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
US20040162235A1 (en) * 2003-02-18 2004-08-19 Trubetskoy Vladimir S. Delivery of siRNA to cells using polyampholytes
US8524213B2 (en) 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
NO20044818D0 (no) 2004-11-05 2004-11-05 Bioforsk As Spermin i kosmetiske preparater
US20060105022A1 (en) 2004-11-15 2006-05-18 Shiseido Co., Ltd. Process for preparing crosslinked hyaluronic acid gel
WO2006056204A1 (en) 2004-11-24 2006-06-01 Novozymes Biopolymer A/S Method of cross-linking hyaluronic acid with divinylsulfone
EP1884231A1 (en) 2006-08-01 2008-02-06 Auriga International S.A. Cosmetic or pharmaceutical composition containing hyaluronic acid
FR2908415B1 (fr) 2006-11-10 2009-01-23 Abr Dev Sarl Acide hyaluronique reticule et son procede de preparation
EP2366386A4 (en) * 2008-10-28 2013-11-27 Univ Santiago Compostela NANOPARTICULAR SYSTEMS MADE OF ANIONIC POLYMERS
FR2945293B1 (fr) * 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
ES2368307B1 (es) * 2010-04-28 2012-10-17 Universidade De Santiago De Compostela Hidrogeles elaborados a base de polímeros aniónicos de origen natural.
US9017712B2 (en) * 2010-07-12 2015-04-28 Shin Poong Pharmaceutical Co., Ltd. Filler composition for tissue reinforcement

Also Published As

Publication number Publication date
US20150272851A1 (en) 2015-10-01
JP2016507592A (ja) 2016-03-10
EP2912074A1 (en) 2015-09-02
AU2013336274B2 (en) 2017-08-24
HRP20191196T1 (hr) 2019-10-18
US10307362B2 (en) 2019-06-04
WO2014064632A1 (en) 2014-05-01
HUE044362T2 (hu) 2019-10-28
US9907739B2 (en) 2018-03-06
EP2912074B1 (en) 2019-05-01
BR112015009162A2 (pt) 2017-10-03
FR2997014A1 (fr) 2014-04-25
EP2912074B2 (en) 2021-12-22
CA2888616C (en) 2020-09-15
DK2912074T4 (da) 2022-03-14
PT2912074T (pt) 2019-07-19
RU2015118969A (ru) 2016-12-20
RS59079B1 (sr) 2019-09-30
AU2013336274A1 (en) 2015-05-07
ES2735017T3 (es) 2019-12-13
DK2912074T3 (da) 2019-07-22
BR112015009162B1 (pt) 2021-10-13
PL2912074T5 (pl) 2022-04-04
SI2912074T1 (sl) 2019-08-30
CA2888616A1 (en) 2014-05-01
FR2997014B1 (fr) 2015-03-20
ES2735017T5 (es) 2022-04-28
US20180140530A1 (en) 2018-05-24
KR102178252B1 (ko) 2020-11-13
RU2653729C2 (ru) 2018-05-14
KR20150079786A (ko) 2015-07-08
PL2912074T3 (pl) 2019-09-30
JP6521862B2 (ja) 2019-05-29

Similar Documents

Publication Publication Date Title
TR201911149T4 (tr) Dermal enjekte edilebilir steril bileşim.
CY1124924T1 (el) Φαρμακευτικη συνθεση καρβετοκινης
CL2015002710A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso.
BR112018005295A2 (pt) terapias com célula t car com eficácia aumentada
EA201792354A1 (ru) Композиции обетихолевой кислоты и способы применения
EA201890201A1 (ru) Антибактериальные соединения
TR201905072T4 (tr) Bitkilerde abiyotik gerilime karşı toleransın arttırılmasına yönelik yöntemler.
CL2016000188A1 (es) Composiciones de arní de serpinc1 y métodos de uso de las mismas
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
BR112016014410A2 (pt) terapia de combinação com vacina de neoantígeno
BR112015028152A2 (pt) inibidores de acc e usos dos mesmos
TR201901886T4 (tr) DNA-PK inhibitörleri.
BR112015011244A2 (pt) Análogos de compstatina de ação prolongada, método de fabricação e uso dos mesmos, bem como composição de qualidade farmacêutica
EA201990616A3 (ru) Дендримероподобные аминоамиды, обладающие активностью блокаторов натриевых каналов, для лечения сухости глаз и других заболеваний слизистых оболочек
EA201590703A1 (ru) Ингибиторы mek при лечении вирусных заболеваний
BR112015028214A2 (pt) inibidores de acc e usos dos mesmos
TR201903565T4 (tr) Yara iyileşmesi için yöntemler ve bileşimler.
IN2015DN03307A (tr)
CO2017001624A2 (es) Aminas de bajo voc como un componente de superficie activa en dispersiones
BR112019004332A2 (pt) géis injetáveis que compreendem ácido hialurônico reticulado e hidroxiapatita, composição e processo de fabricação dos mesmos
TR201903037T4 (tr) Bitki köklerinin daldırılma işlemine yönelik bileşim.
EA201791151A1 (ru) Новая кристаллическая форма производного бензимидазола и способ ее получения
CY1119067T1 (el) Διασταυρουμενο υαλουρονικο οξυ, διαδικασια για την παρασκευη του και χρηση αυτου στο αισθητικο πεδιο
CY1121000T1 (el) Sirna και χρηση αυτου σε μεθοδους και συνθεσεις για την θεραπεια ή/και προληψη οφθαλμικων καταστασεων
BR112014023957A2 (pt) agonistas dos receptores adrenérgicos alfa-2